single-center study evaluating the outcomes of patients with aml who relapsed after allosct
Published 1 year ago • 64 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
0:48
pre-measure study: assessing the role of ngs mrd in patients with aml receiving sct
-
2:02
relapse incidence post-allosct with ptcy for aml in cr1
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
8:57
outcomes of sct in t-all and t-lbl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
11:48
fab classification of aml pathology made easy | acute myeloid leukemia classification|#speedymedical
-
52:51
conducting a risk assessment for money laundering
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
14:43
current research into post-allosct maintenance therapy in aml
-
2:05
the surpass-et study: evaluating novel treatment approaches in et
-
1:51
how can we assess quality of life in aml patients?
-
3:51
assessing high-risk aml
-
1:48
do all patients require maintenance therapy following allosct?
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
3:59
single-cell transcriptomic analysis of b-all: leukemia cell state and genetic alterations
-
2:05
investigating mutation order in aml using single-cell sequencing
-
0:45
difference between quality of life & patient-reported outcomes